Search

23 Feb 2024: Site Search. Leading Cambridge neuroscientist appointed as Executive Chair of Medical Research Council. ... Department of Clinical Neurosciences. Featured news. Leading Cambridge neuroscientist appointed as Executive Chair of Medical Research Council.

23 Feb 2024: an early stage, according to new research from a team of scientists led by Professor James Rowe at the University of Cambridge. ... Images, including our videos, are Copyright University of Cambridge and licensors/contributors as identified.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. MS Society Press Release on the bexarotene trial. ... Professor Alasdair Coles from the University of Cambridge, who led the research, said: “The lessons we’ve learned are incredibly exciting, as

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. ORION: Outcomes Research in Inherited Optic Neuropathies. ... Research aims:. The aim of this study is to understand how inherited optic neuropathies progress over time.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Personalised Treatments in Multiple Sclerosis (Brown Group). ... Will Brown. Group Lead. NIHR Advanced Fellow and Senior Research Associate at the University of Cambridge; visiting research fellow at

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Trial REadiness in Ataxia Telangiectasia (TREAT-AT). ... We will ask participants to:. Attend up to 3 visits at Addenbrookes Hospital, Cambridge, over a two year period.

23 Feb 2024: SOUND Laboratory. Research projects. MRC Senior Fellowship Hearing Research (MR/S002537/1). Developing electrophysiological measures of brain activity to optimise cochlear implant (CI) outcomes. ... The BEARS project is funded by the National Institute

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. The role of Nicotinamide Riboside in mitochondrial biogenesis (NR). ... 2024 University of Cambridge.

23 Feb 2024: Department of Clinical Neurosciences. Featured news. Promising molecule targets protein to offer hope for people with Parkinson’s. ... Its mission is to find a cure and improve life for everyone affected by Parkinson’s through cutting edge research,

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. CCMR2: A Trial of Metformin and Clemastine as Remyelinating Drugs in MS. ... Alasdair Coles, February 2023. This trial has been approved by a Research Ethics Committee:.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. Long term follow-up from phase 3 alemtuzumab trials: 11-13 years after first dosing! ... Coles Ther Adv Neurol Disord 2023, Vol. 16: 1–16. Filed Under: News.

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. International Centre for Genomic Medicine in Neuromuscular Diseases (ICGNMD). ... Research aims:. • To identify the genetic causes of neuromuscular and other neurogenetic conditions. •

23 Feb 2024: and Neuroscience M.Sc. at Newcastle University, after which he joined the lab of Rita Horvath, moving with the laboratory to Cambridge in winter 2018. ... 2024 University of Cambridge.

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. The effects of oxygen in the context of mitochondrial dysfunction (Mitox). ... so. Research aims:. • To learn more about the role of oxygen in people with mitochondrial disease and in other conditions

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. 11C]PK11195 PET as a biomarker to diagnose and monitor natural history in mitochondrial disease. ... What is involved? The study involves a screening visit and one study visit at the Wolfson Brain Imaging

23 Feb 2024: Department of Clinical Neurosciences. Featured news. Drug incorporated into silicone coating reduces ‘foreign body reaction’ to implants. ... Images, including our videos, are Copyright University of Cambridge and licensors/contributors as identified.

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. A prospective natural history study of patients with autosomal dominant optic atrophy (FALCON). ... Research aims. The aim of this commercially sponsored, natural history study is to evaluate the rate of

23 Feb 2024: To help answer this question, researchers at the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust turned to UK Biobank, a biomedical database and research resource containing anonymised genetic, ... The research was funded

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. A retrospective study of subjects with a mutation in the MTRFR/C12orf65 gene causing complex Charcot-Marie-Tooth disease Type 6 (CMT6). ... Share any copies of medical notes, clinic letters or test results

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Development of a patient reported outcome measure (PROM) for patients with inherited optic neuropathy (ION). ... 2024 University of Cambridge.

23 Feb 2024: tremendous work we are doing at the University of Cambridge Department of Haematology.”. ... Professor Adrian Liston. Senior Group Leader, Babraham Institute, Senior Research Fellow, Churchill College.

23 Feb 2024: The trial is a collaboration with colleagues at Skåne University Hospital, the University of Cambridge, Cambridge University Hospitals NHS Foundation Trust (CUH), and Imperial College London. ... Images, including our videos, are Copyright University of

23 Feb 2024: This research could allow cell-based therapies to become the norm in the treatment of brain diseases. ... 2017; 20:135–148. This work is supported by the European Commission, MRC, NIHR Cambridge Biomedical Research Centre, Parkinson’s UK, Cure

23 Feb 2024: The research was supported by the Medical Research Council, Fight for Sight, the Bill and Melinda Gates Foundation, Cambridge Eye Trust and the National Eye Research Council. ... Images, including our videos, are Copyright University of Cambridge and

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Understanding the progression over time of hereditary spastic paraplegia (HSP), ataxia and related conditions (PROSPAX). ... Study Website. For further information about the study, please visit the2024

23 Feb 2024: Department of Clinical Neurosciences. Featured news. International study recommends replacing skull section after treatment for a brain bleed. ... Images, including our videos, are Copyright University of Cambridge and licensors/contributors as identified

23 Feb 2024: In a study published today in Nature Communications, a team led by scientists at the UK Dementia Research Institute, University of Cambridge, has identified a new mechanism that appears to reverse ... Avezov from the UK Dementia Research Institute at the

23 Feb 2024: Angelos Kolias, Consultant Neurosurgeon at Cambridge University Hospitals NHS Foundation Trust (CUH) and NIHR Global Neurotrauma Research Group associate director, said: “The results show that overall mortality is low, reflecting the ... David Clark, a

23 Feb 2024: Study lead Dr Kamen Tsvetanov, an Alzheimer’s Society Dementia Research Leader Fellow in the Department of Clinical Neurosciences, University of Cambridge, said: “Our ability to solve abstract problems is a ... Dr Ethan Knights from the Medical

23 Feb 2024: The trial was funded by the National Institute for Health Research (NIHR), with further support from the NIHR Cambridge Biomedical Research Centre, the NIHR Brain Injury MedTech Co-operative, the Royal ... could lead to a worse outcome than receiving no

23 Feb 2024: Department of Clinical Neurosciences. Featured news. Early-stage stem cell therapy trial shows promise for treating progressive MS. ... Images, including our videos, are Copyright University of Cambridge and licensors/contributors as identified.

8 Feb 2024: Clinical Multiple Sclerosis Research/a./p News from our work experience students https://www-neurosciences.medschl.cam.ac.uk/cambridge-clinical-ms-research/news-from-our-work-experience-studewnts/ Alasdair Coles ... uk/cambridge-clinical-ms-research/news-

23 Feb 2024: Department of Clinical Neurosciences. Featured news. Cambridge to lead new research platform to transform treatment of traumatic brain injury in the UK. ... UK-wide research platform, TBI-REPORTER, which will be led by the University of Cambridge.

23 Feb 2024: Department of Clinical Neurosciences. Featured news. Gene therapy injection in one eye surprises scientists by improving vision in both. ... Images, including our videos, are Copyright University of Cambridge and licensors/contributors as identified.

23 Feb 2024: She has extensive research experience in: improving speech perception for profoundly deafened adults; understanding cochlear dead regions; speech and language development in children; training pitch perception; auditory psychophysics and using

23 Feb 2024: Horvath Laboratory. Catarina Olimpio. Catarina Olimpio. MBChB. Catarina is a Clinical Genetics specialty registrar at Cambridge University Hospitals currently undertaking a research block with Professor Horvath. ... 2024 University of Cambridge.

23 Feb 2024: Her research interests include combining electrophysiological and behavioural measures to optimise cochlear implant (CI) fitting, focusing especially on pitch and envelope processing. ... Her current research focus is on determining how speech-envelope

23 Feb 2024: Horvath Laboratory. May Yung Tiet. May Yung Tiet. PhD. May is an Honorary Clinical Research Associate studying the role of mitochondrial dysfunction in Ataxia-Telangiectasia. ... She completed her BSc (Hons) Biomedical Science in 2006 and was a Research

23 Feb 2024: Before joining the Department of Clinical Neurosciences at the University of Cambridge, he researched the role of mitochondrial dysfunction in Parkinson’s disease at the UCL Queen Square Institute of Neurology. ... 2024 University of Cambridge.

23 Feb 2024: The research focused on understanding spatial speech in noise perception for listeners with bimodal hearing devices, i.e. ... Contact. Contact Us. 2024 University of Cambridge.

23 Feb 2024: 2024 University of Cambridge.

23 Feb 2024: Contact Us. 2024 University of Cambridge.

23 Feb 2024: Horvath Laboratory. Margarita Chudenkova. Margarita worked as a Research Assistant in the Horvath lab. ... Margarita completed her MSc Degree in Molecular Biology at the International Max Planck Research School in Goettingen, Germany.

23 Feb 2024: SOUND Laboratory. Rajeev Mathew. Rajeev graduated in medicine with a triple first from Cambridge University and Distinction from University College London in 2006. ... Undurraga. Rajeev is currently completing a 2 year surgical fellowship in otology,

23 Feb 2024: Juliane Mueller, PhD. Margarita Chudenkova. Tomas Ferreira. 2024 University of Cambridge.

23 Feb 2024: SOUND Laboratory. Giorgos Dritsakis. Giorgos is a Research Associate working on the BEARS project (Both Ears virtual acoustics training package for bilateral cochlear implant users). ... Giorgos’ research interests include: telehealth, patient-reported

23 Feb 2024: Horvath Laboratory. Juliane Müller. Juliane worked as a senior research associate in Prof. ... In 2014, she started working in Prof. Horvath’s group, first at the Institute of Genetic Medicine and the Wellcome Trust Centre for Mitochondrial Research

23 Feb 2024: Her PhD builds on the research she carried out during her MSc and investigates how speech is used in the clinical hearing assessment process. ... Bhavisha’s research interests include: development of ear and hearing care services in low resource

23 Feb 2024: Before joining the University of Cambridge, Mariana completed her BA in Neuroscience and Global Health at Northwestern University in 2022. ... 2024 University of Cambridge.

23 Feb 2024: Horvath Laboratory. Research Projects. UKRI Medical Research Council. Project: Targeting the cellular metabolism to treat tissue-specific mitochondrial diseases. ... Yavuz Oktay at the Dokuz Eylul University. Lily Foundation – Research Grant.